The 2025 Budget comes at a crucial time for the UK’s innovative life sciences and biotech sector, which finds itself at the mercy of global geopolitical forces and a prolonged funding draught. This Budget could deliver much needed relief or further bad news, as the Chancellor deals with a precarious financial landscape.
Despite the government’s welcome identification of the life sciences as a priority growth sector, and the launch of the Sector Plan, there are still many rumoured policies that could impact the sector, including adjustments to business rates for R&D facilities and the raising of taxes such as Capital Gains, alongside potential updates on Mansion House and the work of public institutions such as the British Business Bank and National Wealth Fund.
Join BIA’s team that has been campaigning on behalf of the sector to hear their analysis of the key announcements and their impact, as well as how the announcements align with the commitments made by government in the Life Sciences Sector plan, and the broader industrial strategy.
Martin Turner
What does your role at BIA involve?
Martin leads the BIA's policy and public affairs team, overseeing all of the BIA's policy development work, Advisory Committees and engagement with government and other stakeholders. He also supports the BIA Chair, Dan Mahony, in his role as the Government's Life Sciences Investment Envoy and leads BIA's investor relations. He is chief editor of BIA's finance reports and a regular commentator on the life sciences sector in the national media.
Previous experience & achievements
Outside BIA, Martin serves on the Advisory Board of the Cambridge University Science Policy Exchange (CUSPE). He has over fifteen years experience in policy and public affairs and has worked at the Royal Society, the Campaign for Science and Engineering, and the Association of Medical Research Charities. He holds a PhD in molecular biology from the University of Sheffield.
BIA Annual Supporters
